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Abstract 
Background: Chronic pain is predominantly managed in primary care, although often 
ineffectively. There is growing evidence to support the potential role of nurses and 
pharmacists in the effective management of chronic pain. 
Objective: To evaluate the effectiveness of a pain clinic jointly managed by a nurse and 
pharmacist. 
Design: A mixed-methods design consisting of qualitative interviews embedded within a 
quasi-experimental study. 
Settings: A community-based nurse-pharmacist led pain clinic in the north of England.  
Participants: Adult chronic pain (non-malignant) patients referred to the pain clinic.  
Methods: Pain intensity was the primary outcome. Questionnaires (The Brief Pain 
Inventory (BPI), the Hospital Anxiety and Depression scale (HADS), the SF-36 and the 
Chronic Pain Grade (CPG) questionnaire) were administered at the baseline, on 
discharge and at 3-months post discharge (BPI and HADS only). Patient satisfaction 
was explored using face-to-face, semi-structured qualitative interviews. 
Results: Seventy nine patients with a mean age of 46.5 years (SD ±14.4) took part in 
the quasi-experimental study. Thirty-six and nine patients completed the discharge and 
3-month follow-up questionnaires respectively. Compared to baseline, statistically 
significant reductions were noted for two of the outcome measures: pain intensity 
(P=0.02), and interference of pain with physical functioning (P=0.02) on discharge from 
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the service. Nineteen patients participated in qualitative interviews. The patients were, 
in general, satisfied with the quality of service. Four contributing factors to patient 
satisfaction were identified: ample consultation time; in-depth specialised knowledge; 
listening and understanding to patients’ needs; and a holistic approach. 
Conclusion: Nurse and pharmacist managed community-based pain clinics can 
effectively deliver quality pain management services as they offer an interdisciplinary 
holistic approach to pain management. Such services have the potential not only to 
reduce the burden on secondary care but also decrease long waiting times for referral 
to secondary care. Further research is required to support the development of evidence 
based referral guidelines to such services.   
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Introduction: 
Chronic (non-malignant) pain affects millions of adults globally, disrupting their 
personal, social and professional lives, and contributing significantly to the overall 
burden on healthcare systems and society. Chronic pain patients utilize significantly 
more healthcare resources than patients with other long term conditions [1, 2]. In the 
US, the overall annual cost associated with chronic pain has been estimated to range 
from $560 to $635 billion (£ 341 billion to £387 billion), more than the annual costs of 
heart disease ($309 billion; £188 billion), cancer ($243 billion; £148 billion), and 
diabetes ($188 billion; 114 £billion) [3]. 
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In most instances, chronic pain patients are managed within primary care. However, 
issues like under treatment of chronic pain [4], abuse of opioid analgesics [5], lack of 
monitoring of repeat prescriptions leading to deteriorating patients’ quality of life [6], and 
increasing burden on secondary care have been well documented in the literature, 
necessitating development of specialised community-based pain management services. 
There is growing evidence to support the role of nurses and pharmacists in chronic pain 
management [7, 8, 9]. Pharmacist-led interventions have been shown to reduce pain 
intensity, improve physical functioning and reduce adverse events among chronic pain 
patients [7]. Similarly, nurse-led interventions have been shown to reduce the chronic 
use of non-steroidal anti-inflammatory drugs (NSAIDs) [8], and improve physical 
functioning [9] and self-management skills.    
Keeping in view the potential usefulness of nurses and pharmacists in chronic pain 
management and the limited capacity of general practitioners (GPs) in managing 
chronic pain, the Leeds Community Healthcare NHS Trust, part of the UK National 
Health Service, initiated a nurse-pharmacist managed pain clinic for patients with 
chronic pain in the community setting. The working of the clinic has been described in 
detail elsewhere [10]. Briefly, the role of the pharmacist, who spent one day per week at 
the pain clinic, was to conduct medication review with the aim of ensuring safe and 
effective use of analgesics. The nursing intervention focused on educating patients 
about pain, clarifying any misconceptions, and encouraging patients to develop self-
management skills. A retrospective study reported a significant reduction in pain 
intensity (P < 0.001) [11]. However, the small sample size and the use of pain scores 
alone as an outcome measure, limit the usefulness of the findings. The present study 
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was designed to further build on the existing research evidence on the effectiveness of 
the pain clinic using a mixed-methods approach.  
Methods 
Among various mixed-methods designs available, an embedded design 
consisting of a quasi-experimental (quantitative) study and a descriptive qualitative 
study was chosen [12]. In embedded design there is one principal method (qualitative or 
quantitative) and it is given priority depending on the purpose of the research and the 
other method provides supportive data [12]. The embedded design is particularly useful 
when a single dataset is not sufficient and different questions requiring different 
methodologies need to be answered within a single study [12]. The rationale for 
choosing an embedded design has been discussed in detail elsewhere [13]. The study 
was conducted at a pain clinic, situated in the north of England. The ethics approval 
was obtained from the local NHS ethics committee (Ref no. 11/YH/0415) 
All patients referred to the pain clinic were assessed for eligibility to participate in 
this study by the first author (MAH) and/or clinical nurse specialist (KM). Patients 
meeting the following inclusion criteria were invited to participate: age >18 years, history 
of pain for >3 months and adequate ability to read and understand English. Pregnant 
women and patients with malignant pain, psychiatric disorders or requiring acute 
medical/surgical intervention for their pain relief were excluded. The required sample 
size was calculated to be 79, with 80% power, a 95% confidence interval, a minimum 
clinically important difference of 1.1 points (on 0-10 Numerical Rating Scale for pain 
intensity) and anticipating a 15% dropout rate [14]. The minimum clinically important 
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difference was considered for sample size calculation so that the study was powered 
sufficiently to at least detect minimum clinically important differences. 
Outcome measures 
Outcome measures included: pain intensity (primary), physical functioning, 
emotional functioning, quality of life and chronic pain grade. Pain intensity and physical 
functioning were assessed using the Brief Pain Inventory (BPI) – a valid and reliable 
tool which assesses pain intensity (average, least, worst, pain right now) and pain 
interference with 7 daily life activities, including general activity, walking, work, mood, 
enjoyment of life, relations with others and sleep [15].  The 14-item Hospital Anxiety and 
Depression Scale consisting of 2 subscales: Anxiety (HADS-A) and Depression (HADS-
D) was used to assess emotional functioning [16]. The mean cut-off score for HADS-A 
and HADS-D was 8, to indicate anxiety and depression, respectively [16]. The SF-36, a 
generic valid and reliable questionnaire, was used to assess quality of life [17]. Pain 
severity was assessed using the chronic pain grade (CPG) questionnaire, a 7-item 
questionnaire that classifies chronic pain patients into one of the four hierarchical 
categories according to pain severity: grade I, low disability–low intensity; grade II, low 
disability–high intensity; grade III, high disability–moderately limiting; and grade IV, high 
disability–severely limiting [18]. 
Demographic and clinical data were collected using a standardized, pilot-tested, 
and structured questionnaire by reviewing case notes and patient interviews (by MAH). 
The patients completed four self-administered questionnaires (mentioned above) 1) on 
their first visit to the clinic, 2) on discharge (last visit) from the clinic and 3) 3 months 
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after discharge. The 3-month follow-up questionnaires (only the Brief Pain Inventory and 
the Hospital Anxiety and Depression Scale) were mailed to the respondents in a prepaid 
self-addressed return envelope, limited to the first 30 discharged patients only. 
Qualitative phase 
For the descriptive qualitative study, semi-structured, face-to-face interviews 
were conducted using an interview guide. The patients were interviewed within 2 weeks 
of their discharge by MAH either at patients’ homes or at the pain clinic, depending on 
their preference. A combination of two purposive sampling techniques, convenience 
sampling and maximum variation sampling [19], were used to recruit patients. Initially for 
the first five interviews, convenience sampling was used and patients meeting the 
inclusion/exclusion criteria and consenting for an interview were recruited. In order to 
ensure representation of different types of patients referred to the clinic, the remaining 
14 interviewees were recruited using maximum variation sampling. Patients of different 
ages, sexes and pain scores (baseline and discharge) were interviewed to ensure 
diversity. “Data saturation”— whereby no new themes emerged from the data guided 
sample size [19]. Interviews were audio-recorded using an electronic audio recorder. 
The interview topic guide was designed to cover the following areas: expectations from 
the service; efficacy of the service (did it help? how?); interaction with nurse and 
pharmacist (time given for consultation, engaging patient in discussion and designing of 
therapeutic plan, listening to and understanding the problem); understanding of chronic 
pain and self-management; and overall satisfaction with the service (experience 
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compared to other services in past, aspects of the service which need improvement 
etc.).  
Data analysis 
The quantitative data were analysed using Statistical Package for Social Sciences 
(SPSS) for Windows version 20. For scoring SF-36, a scoring software provided by the 
Quality Metric Incorporated (QM), Lincoln RI, USA was used. Since data were paired, 
either the paired t-test or the Wilcoxon Signed-Rank test was used as appropriate. To 
improve clinical interpretation of the results, based on the recommendations of the 
IMMPACT group on benchmarks for interpreting clinically important change [20], the 
number of patients demonstrating a minimum clinically important difference was also 
highlighted. 
Thematic analysis was used to analyze the qualitative data [19]. Each interview was 
transcribed verbatim by a professional transcriber and each transcript was checked 
against the original recording by the first author (MAH) for accuracy. Following this, 
each transcript was coded manually line by line by the first author (MAH). The initial 
coding framework was checked by another two authors (MB, SJC) for accuracy and 
completeness by reviewing two coded interview transcripts. Once all the interviews 
were coded, a list of all the codes was generated after removing duplicates and different 
codes were sorted into potential themes. The relevant data extracts were collated within 
these potential themes. As the new themes emerged, old ones were reviewed and 
sometimes renamed in the light of the emergence of new themes. The process 
continued until the no new themes were generated.  
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To ensure the credibility and transferability of qualitative findings, peer review/debriefing 
and providing rich thick description were used [21]. Peer review/debriefing was carried 
out by two senior qualitative researchers (SJC and MB).  A detailed description of the 
study settings, participants, sampling technique, and data analysis method has been 
provided to ensure transparency of the findings. 
Results: 
Quantitative Phase 
Sociodemographics  
In total, 79 patients were enrolled in the quantitative phase with a mean age of 46.5 
years SD ± 14.5 (range 22-86). Approximately, two thirds (67.1%) of the patients were 
female and more than half of the patients (57.0%) were married or living with partner. 
Slightly more than a quarter of the patients (25.3%) were unemployed due to pain 
(Table 1). Low back (68.4%) followed by lower limb (58.2%) were the most commonly 
reported pain sites. The majority of patients 56 (70.9%) reported to have never been 
referred to a pain clinic/ pain consultant in the past.  
The follow-up (discharge) data were available for 36 patients only as the data collection 
had to be stopped because the service was unexpectedly decommissioned by the local 
Primary Care Trust. For the 3-month follow-up, of the 30 patients invited, only nine 
completed and returned the questionnaires. Therefore, keeping in view poor response 
rate and subsequent small number of participants, the 3-month follow-up data were not 
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analyzed statistically as it would have been misleading. The implications of early 
cessation of data collection have been discussed in the limitations section.   
Outcome measures 
Pain intensity was the primary outcome. Pain intensity scores were available for 79 
and 35 patients at baseline and discharge respectively. Upon discharge, there was a 
statistically significant reduction for worst pain (P = 0.02) and average pain (P = 0.02). 
However, for least pain and pain right now the reduction in pain intensity score was not 
statistically significant (P = 0.12) and P=0.06 respectively (Table 3). Thirteen (37.1%) 
patients achieved a minimum clinically important difference (10-20% decrease in pain 
intensity [20]) while two (5.7%) each achieved a moderately important (≥ 30% decrease 
[20]) and substantially important differences (≥50% decrease [20]) as per the 
recommendations of IMMPACT group on interpreting clinically important changes.  
The overall interference of pain with physical activity scores were available for 79 
and 36 patients respectively. There was a significant reduction (P = 0.02) in overall 
interference of pain with physical functioning upon discharge compared to the baseline 
score. Fourteen (40%) patients achieved a minimum clinically important difference, at 
least one point improvement on a 0 to 10 NRS, as per the recommendations of 
IMMPACT group on benchmarks for interpreting clinically important changes for 
physical functioning [20].  
For quality of life (SF-36), there were no statistically significant differences in the 
physical component summary (PCS) scores (P=0.15) or the mental component 
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summary (MCS) scores (P=0.08). For individual domain scores, compared to the 
baseline score, statistically significant improvements were found in physical role (RP) 
(P= 0.01), bodily pain (BP) (P=0.01) and social functioning (SF) (P=0.03) at discharge.  
For anxiety and depression, both HADS-A and HADS-D were divided into four 
ranges: normal (0-7); mild (8-10); moderate (11-15); and severe (16-21).  Almost two-
thirds of the patients (67.1%) had HADS-A scores more than 7, i.e. were likely to have 
an anxiety disorder (Table 3). Compared to the baseline, there was no statistically 
significant reduction in the median HADS-A (P= 0.21) or HADS-D scores (P = 0.22). 
However, for 13 (38.2%) and seven (20.6%) patients there was a reduction in the 
severity of anxiety and depression respectively by at least one category (e.g. moderate 
to mild or severe to moderate etc.). 
  For the CPG, the median pain intensity score was 76.66 (total score 100) (IQR 
66.67; 83.33) and the median for disability score was 70 (60.00; 90.00) at baseline. 
Compared to the baseline, there was a statistically significant reduction in pain intensity 
(Median 73.33; IQR 55.00; 83.33) at discharge (P = 0.02). However, no statistically 
significant improvement in disability score was found (P = 0.89) at the discharge 
(Median 73.33; IQR 51.66; 91.67). In terms of change in chronic pain grade, 7 (20.6%) 
patients reported improvement by at least one grade. However, the majority of the 
patients, 21 (61.7%) did not report any improvement (Table 3). 
Nature of intervention 
Data on the nature of the intervention were available for 35 patients (Table 4). The 
mean number of visits made by each patient to the pain clinic was 3.05 (S.D=0.97) 
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(Range 2 to 6). Fourteen (40%) of the patients were discharged after 3 visits (Table 4). 
In total, 101 medicine-related recommendations were made to the GP with a mean of 
2.9 (range 1 to 6) recommendations per patient. For most of the patients [22 (62.8%)] 3 
to 5 medicine-related recommendations were made to their GPs. Adding a new drug (n 
= 30) followed by titrating the dose (n = 29) were the most commonly made 
pharmacological recommendations. In addition, 34 non-pharmacological 
recommendations were made in total with a mean of 1.3 (range 1 to 3) per patient. 
Among non-pharmacological recommendations, pacing of activities (n = 18) was the 
most common.  
Qualitative Phase 
In total, 19 participants recruited from the quantitative study sample, including eight men 
and eleven women were interviewed. The age of the participants ranged from 27 to 74 
years. Ten interviews were conducted at patients’ homes, eight at the pain clinic and 
one at the patient’s office (during their lunch break). Interviews lasted between 25 and 
45 minutes. The sociodemographic characteristics of the participants are given in Table 
5. 
Satisfaction with the service 
In general, the majority of the patients were satisfied with the quality of care that they 
received at the pain clinic. Four factors were identified during the data analysis which 
contributed towards positive patient experience with the service: ample consultation 
time, listening and understanding individual patients’ needs, in-depth specialised 
knowledge, and a holistic approach.  
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“I think it’s a good little service that they’ve got going on there; I really, 
really do.” [Pt. 12, 39 years old female] 
a. Ample consultation time 
The patients felt that they were given full freedom and time to express their views. In 
contrast to the ten minute consultation slot with the GP, the patients had one hour for 
the initial consultation and 30 to 45 minutes for the follow-up appointments which 
allowed them to discuss their problems more openly and freely. 
“You’re very conscious of the amount of time you have with your GP and it 
was knowing that I was going to see somebody who actually is a pain specialist, 
you just feel more confident and that because you feel they will take time with 
you and listen to you and understand…” [Pt. 16, 54 years old female] 
“When you come here you don’t feel that pressure, so you can be a bit 
more open and a bit more frank and you can be a bit more descriptive.” [Pt. 8, 40 
years old female] 
b. In-depth specialised knowledge 
The in-depth specialised knowledge of both the nurse and pharmacist in terms of 
chronic pain management was quickly recognized by the patients.  
“I think there’s also that knowledge base here. They’re obviously treating 
or speaking with people that have got similar symptoms and therefore know what 
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kind of route to take when it comes to pain management and so on.” [Pt. 8, 40 
years old female] 
 “[The clinical nurse specialist]  explained what’s going off, how it affects 
me, and then [Pharmacist]  we’ve been sat down and we’ve been balancing all 
my medications out, how much there is to take and how much… and what to take 
and what not to take, you know.  So it’s been a real…to me it has, it’s been a 
really good thing to have been coming up here to the pain clinic.”  [Pt. 13, 54 
years old male] 
The pharmacist focused on optimising the use of analgesics and other medicines 
involved in pain management. The patients were informed about the side effects and 
negative impact of over/under dosing.   
“I felt she was very professional and she knew what she was doing, which is 
comforting. I’ve seen the pharmacist on Tuesday and the way she sort of looked at my 
medication and she knows what everything’s doing, she knows what it should be doing, 
and she probably knows what I can do without, hence the tramadol [was taken off].” [Pt. 
10, 54 years old female] 
c. Listening and understanding individual patients needs 
The patients found that both the nurse and the pharmacist expressed their interest in 
listening to patients’ views, in contrast to the GPs who the patients perceived as not 
being interested in obtaining a full medical and medication history. Based on thorough 
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face-to-face interviews, the nurse and pharmacist developed a therapeutic plan in 
consultation with the patients.  
“She [the clinical nurse specialist] was very good at listening.  She was, 
very good. It was lovely having somebody to talk to who understood what pain 
does to people and you could talk to her, she were a person that you could talk 
to, some you can’t [ slight pause] can you, you know?  Some people, they just 
give off that aura, they don’t really care, you know.  But she were very good, she 
was yes.” [Pt. 14, 64 years old female] 
“I think it’s because there’s a sympathetic ear and people will listen.  And 
there seems as if this understanding and they’re offering advice that we’ll take on 
board, whereas we’ve not really had that… we’ve not felt that comfortable with 
the GP because she openly admitted that she didn’t really know anything about 
fibromyalgia and therefore she didn’t really know how to treat it.” [Pt. 8, 40 years 
old female] 
d. Holistic approach 
The clinic offered a more holistic approach towards pain management compared to the 
GP. Both pharmacological and non-pharmacological therapeutic options were explored 
for each patient and individualized therapeutic plans were developed.  
“Well really I suppose here they go through absolutely everything you 
know so it’s a lot more in-depth and looking at the whole picture rather than 
simply trying to give you medication for a problem like the GP does and then 
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refer you to physio etc. It’s……..[Pauses].  Here it’s a much more holistic 
approach really and they try and cover absolutely everything for you and see 
what other services they may be able to refer you to or ask your GP to refer you 
to. So I think really it’s a complete programme so it’s good in that way.” [Pt.11, 44 
years old female] 
After assessing individual patient’s needs, the patients were also referred to other 
services such as the expert patient groups, musculoskeletal services, and psychological 
services if required. The patients also found these referrals beneficial, contributing to an 
overall satisfaction with the service. 
 “They have taken steps to help the emotional side, which that’s, you 
know, sort of getting out and meeting people.  And [the CNS] picked up on that 
very quickly, very, very quickly.”[Pt. 10, 54 years old female] 
 “They [pain clinic] referred me to a physiotherapist who specialised in 
chronic pain.  And so through seeing that physiotherapist I’ve learnt different 
ways of managing the pain which I found to be more effective than the 
medication I was on.” [Pt. 18, 27 years old female] 
Issues with the pain clinic 
The patients also highlighted some negative issues with this service. They were not 
pleased by the fact that the pain clinic did not prescribe medicines to them and they had 
to go to their GPs to get the medicines. Patients felt that this caused unnecessary delay 
and had expected to get their medicines at the pain clinic. 
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“When I found that I was going to have to go back to him for the 
prescription I was a bit in shock really.  I’m thinking what?  He’s referred me to 
you for you to... saying that you’ll be able to look at these things and I’ve come 
here hopefully to get these things and then you’re saying I’ve got to wait another 
two weeks while you send a letter to my doctor and then he’ll just write a 
prescription....[Pt. 19, 47 years old male] 
Some of the patients also felt that they were not appropriate for this service and should 
not have been referred here. They considered that they had pain for quite a long time 
and knew about the various self-management strategies discussed at the pain clinic 
including being active, exercise and pacing activities. 
“I think it [the service] was more aimed at getting people re-motivated past 
their pain, so we did talk a little bit about painkillers and modified those a bit, but 
the main part of pain clinic to me seemed to be about getting people to get up 
and go and take additional steps that maybe they weren’t already doing, which 
really wasn’t kind of suitable for me I don’t think.  I don’t ever sit down; I don’t 
have time, so I think maybe I wasn’t really their target audience.” [Pt. 1, 36 years 
old female] 
Discussion: 
Over the past few years, there has been growing interest in the use of mixed-methods 
approaches in health services evaluation, as they allow the use of multiple methods to 
comprehensively answer different research questions [9, 21-24]. This study used a 
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mixed-methods approach which generated both effectiveness and satisfaction data 
within a single study, thus providing a holistic evaluation of the service.  
The majority of the patients were women and predominantly middle aged (36-50 years). 
Chronic pain is more prevalent among women and they have been reported to use 
more healthcare resources than men, which may explain the higher number of female 
patients in the sample. More than a half (56.5%) of the patients had had chronic pain for 
more than 3 years and, more importantly, for 70% of the patients this was their first visit 
to a specialised pain service/clinic. The interplay of a number of factors including 
patients’ medical help seeking behavior, GPs’ lack of willingness to refer patients to a 
specialised pain service and, lack of awareness among the GPs and patients about the 
existence of such clinics may partly explain the delay in referral [25]. Importantly, during 
the qualitative interviews quite a few patients highlighted that they had had to repeatedly 
ask their GPs for referral before they were eventually referred.  
Almost two thirds of the patients in our study had anxiety and depression. Anxiety and 
depression are common comorbidities and are associated with poorer prognosis among 
chronic pain patients [26]. Patients in the qualitative interviews highlighted the 
significant impact of chronic pain on their mental and physical functioning and described 
a two way relationship between pain and depression. The National Health Survey in the 
UK reported that participants in chronic pain grade IV (high disability-severely limiting) 
were more likely to be anxious and depressed than the participants with grade I (low 
disability-low intensity) and II (low disability-high intensity) [27]. In the present study, 
more than 60% of the patients fell under Grade IV (high disability-severely limiting), 
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explaining a high incidence of anxiety and depression among patients referred to the 
clinic.  
The recommendations made by the IMMPACT group guided the selection of outcome 
measures [20]. These were statistically significant changes in the “worst pain”, “average 
pain” and pain interference with physical functioning. It has been suggested that the 
population distribution of pain scores do not usually have a  normal distribution and are 
‘U-shaped’; therefore, merely reporting changes in the means/medians for continuous 
data (e.g. pain intensity) can be misleading as patients tend to have either very good or 
very poor pain relief [28]. To avoid this limitation and to improve clinical interpretation of 
the results, percentages of patients responding to treatment have been reported as well 
for two of the outcome measures: pain intensity and physical functioning, as IMMPACT 
group recommendations were available for these two outcomes measures only [20]. No 
statistically significant reductions were noted for anxiety (P=0.21), depression (P=0.22), 
the physical component summary (PCS) score or the mental component summary 
(MCS) score. The lack of intervention effect in terms of anxiety, depression, and quality 
of life might be attributed to the small sample size. It is also possible that the 
intervention was not effective or the outcome measures were not sensitive enough to 
detect a difference. These issues require further exploration. 
Patient satisfaction was explored using face-to-face qualitative interviews. Patients were 
generally satisfied with the quality of care provided by the nurse and the pharmacist at 
the pain clinic. Ample consultation time, in-depth specialized knowledge, listening and 
understanding individual patient’s needs, and a holistic approach were identified as 
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factors contributing to patients’ satisfaction. Non-pharmacological alternatives were 
suggested in instances where the patient had: adherence problems; issues related to 
the side effects/tolerance; or non-pharmacological interventions were considered 
helpful. The holistic approach was evident from the nature of recommendations made at 
the clinic. For 35 patients, 101 medicine-related (mean 2.9; range 1 to 6) and 42 non-
pharmacological recommendations (mean 1.3; range 1 to 3) were made to the GPs and 
patients, suggesting that both pharmacological and non-pharmacological needs were 
assessed and addressed. 
Limitations 
The major limitation of the present study was the inability to meet the desired sample 
size. Discharge data were available for 36 patients only as the service was 
unexpectedly decommissioned by the local primary care trust (PCT). Subsequently, the 
services of the clinical nurse specialist were absorbed into a musculoskeletal service at 
the same community health center and the services of the pharmacist were 
discontinued. Since there were structural changes in the provision of service, collecting 
further follow-up data would not have been appropriate. The inability to gain the 
required sample size (i.e. the study was underpowered) could lead to Type II error, 
explaining a lack of intervention effect on the quality of life, anxiety and depression 
outcomes in the present study. On the other hand, the significant intervention effect on 
pain intensity and physical functioning, might be due to Type I error, a false positive. 
Therefore, the results should be interpreted with care. However, during the qualitative 
interviews patients highlighted the positive impact of the pain clinic on their pain 
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intensity, physical functioning and quality of life. Integrating qualitative and quantitative 
data helped to overcome the sample size limitation by providing patients’ perspectives 
to complement the numerical data. It was deemed inappropriate to employ statistical 
methods to impute missing data, fearing data artificiality, as it accounted for more than 
50% of the data.  Another associated limitation was poor response to 3-month follow-up 
questionnaires despite the fact that personalised letters were sent to patients to improve 
the response rate. Consequently the 3-month follow up data were not statistically 
analysed.  
Conclusion  
Interdisciplinary community based pain clinics jointly run by nurses and pharmacists 
have the potential to improve chronic pain management in the community. In addition to 
reducing pain intensity and improving physical functioning, such community-based 
clinics can not only improve access to specialised pain service but also reduce burden 
on the secondary care. The cost-effectiveness of such services should be evaluated as 
it would aid service commissioners in the design and implementation of such services in 
future. The ample consultation time with patients allowed the nurse and the pharmacist 
to obtain a full medication and medical history and develop an individualised 
management plan addressing both the pharmacological and non-pharmacological 
needs of the patients. In terms of the patients’ perspective, they felt that they were 
treated with respect and empathy and were generally satisfied with the quality of 
service. There is a need to develop evidence-based referral guidelines for such 
community based clinics to ensure that only the patients who are likely to benefit from 
such services are referred there. GPs should be encouraged to refer patients to such 
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services early during the course of the treatment as GPs’ lack of specialised knowledge 
and short consultation time are barriers to effective pain management.  
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Table 1.  Sociodemographic characteristics of the patients 
Characteristic N (%) 
Age  
(Mean: 46.49 ; SD:14.5) Range (22-86) 
 
18-35 18 (22.8) 
36-50 37 (46.8) 
51-65 17 (21.5) 
>65 7 (8.9) 
Gender  
Male 26 (32.9) 
Female 53 (67.1) 
Marital Status  
Single 24 (30.4) 
Married/living with partner 45 (57.0)  
Divorced/separated 6 (7.6) 
Widowed 3 (3.8) 
Undisclosed 1 (1.3) 
Employment status  
Public 3 (3.8) 
Private 19 (24.1) 
Self-employed 3 (3.8) 
Retired 14 (17.7) 
Unemployed (pain) 20 (25.3) 
Unemployed (other reason) 14 (17.7) 
Student  2 (2.5) 
Undisclosed 4 (5.1) 
Ethnicity  
White 67 (84.8) 
White others 3 (3.8) 
Asian/Asian British 6 (7.6) 
Arab 2 (2.5) 
Undisclosed 1 (1.3) 
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Education level  
Undisclosed 10 (12.7) 
GCSE/O-Level 29 (36.7) 
A-level/NVQ 19 (24.1) 
Diploma 5 (6.3) 
Degree 10 (12.7) 
Pain Sites* 
Head, Face and Neck 
Upper shoulder 
Thoracic region 
Abdominal region 
Low back 
Lower Limb 
Pelvic region 
Anal, perineal 
Pain Duration (Years) 
 
39 (49.4) 
28 (35.4) 
7 (8.8) 
5 (6.3) 
54 (68.3) 
46 (58.2) 
7 (8.8) 
2 (2.7) 
< 1 year 13 (16.5) 
1 to 3 21(26.6) 
3-5 19 (24.1) 
5-10 17 (21.5) 
>10 9 (11.4) 
Number of comorbidities  
None 34 (43.0) 
1 19 (24.1) 
2 15 (19.0) 
3 10 (12.7) 
4 1(1.3) 
Past visit of pain clinic/consultant  
No 56 (70.9) 
Yes 23 (29.1) 
* Patients were allowed to choose more than one pain site. 
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Table 2. Comparison of pain intensity, pain interference with physical functioning scores 
at baseline and discharge. 
 N N* Median (IQR) Z **P-value 
BPI Pain intensity      
Worst Pain      
Baseline 79 35 8.0 (7.0;9.0) - 2.4 0.02 
Discharge 35  7.5 (5.0; 8.0) 
Least Pain      
Baseline 79 35 5.0 (3.0; 7.0) -1.5 0.12 
Discharge 35  4.0 (2.0; 6.0) 
Average pain      
Baseline 79 35 7.0 (5.0; 8.0) -.2.3 0.02 
Discharge 35  6.0 (4.0;7.0) 
BPI Pain interference      
Baseline 79 35 7.1 (5.7;8.2) -2.3 0.02 
Discharge 36  6.1 (4.0; 8.7) 
QoL (SF-36)   Mean (SD) T  
PCS      
Baseline 74 33 28.8 (11.0) 1.4 0.15 
Discharge 35  30.8 (12.9)   
MCS      
Baseline 74 33 36.3 (15.1) 1.8 0.08 
Discharge 35  41.2 (14.6)   
N*= Number of patients for whom both baseline and discharge scores were calculated. ** 
Calculated using Wilcoxon-Sign Rank or Paired-T test as appropriate; BPI= Brief Pain Inventory 
PCS = Physical Component Summary score;  MCS =  Mental Component Summary score 
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Table 3: Comparison of Anxiety, Depression and Chronic pain Grade at baseline and 
discharge. 
 Baseline 
N (%) 
N = 76 
Discharge 
N (%) 
N = 34 
Change in 
category  
N (%) 
N = 34 
*P-value  
HADS-A       
Normal 25 (32.9) 14 (41.2) ≤ -1 13 (38.2)  
Mild 14 (18.4) 10 (29.4) 0 13 (38.2)  
Moderate 24 (31.6) 7 (20.6) ≥ 1 8 (23.5)  
Severe 13 (17.1) 3 (8.8)    
Overall score  
(Median (IQR)) 
10 (7.0; 14.0) 8.5 (5.7; 12.2)   0.21 
HADS-D 
     
Normal 30 (39.5) 16 (47.1) ≤ -1 7 (20.6)  
Mild 11(14.4) 5 (14.7) 0 21 (61.8)  
Moderate 27 (35.5) 10 (29.4) ≥ 1 6 (17.6)  
Severe 8 (10.5) 3 (8.8)    
Overall score 
(Median (IQR)) 
10.0 (5.0; 13.0) 8.0 (3.7; 12.2)   0.22 
CPG Grade 
     
I 2 (2.6) 4 (11.8) ≤ - 1 7 (20.6)  
II 13 (17.1) 2 (5.9) 0 21 (61.7)  
III 11 (14.5) 7 (20.6) ≥ 1 6 (17.6)  
IV 50 (65.8) 21 (61.8)    
* Calculated using Wilcoxon-Sign Rank test. HADS-A = Hospital Anxiety and Depression Scale 
– Anxiety; HADS-D = Hospital Anxiety and Depression Scale –Depression; CPG = Chronic Pain 
Grade 
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Table 4. Nature of recommendations made at the pain clinic 
Item  N (%) 
Number of visits  
2 11 (31.4) 
3 14 (40.0) 
4 8 (22.9) 
5 1 (2.9) 
6 1 (2.9) 
Recommendation made to the GP  
Yes 34 (97.1) 
No 1 (2.9) 
Nature of pharmacological recommendation  
Dose titration 29 (28.7) 
Stopping a drug 19 (18.8) 
Adding a new drug 30 (29.7) 
Substituting a drug 23 (22.8) 
Nature of non-pharmacological interventions  
Exercise 7 (20) 
Life style modification 9 (25.4) 
Pacing activity 18 (51.4) 
Referrals  
Physiotherapy 3 (8.5) 
Spinal injection 6 (17.1) 
Psychological therapy 3 (8.5) 
Support group 6 (17.1) 
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Table 5. Demographics of patients participated in qualitative interviews 
ID Age 
in 
Years 
Gender Employment 
status 
Marital 
status 
Chronic 
pain 
duration 
in Years 
Pain 
intensity 
(baseline) 
Pt.1 36 Female Full-time Married 5-10 5 
Pt. 2 49 Male Full-time Married 5-10 5 
Pt. 3 63 Male Retired Married 5-10 5 
Pt. 4 30 Male Full-time Married 5-10 6 
Pt. 5 74 Female Retired Undisclosed < 1 0 
Pt. 6 58 Female Unemployed Divorced > 10 7 
Pt. 7 39 Male Unemployed Single 1- 3 7 
Pt. 8 40 Female Part-time Married < 1 7 
Pt. 9 51 Male Part-time Married 3-5  10 
Pt. 10 54 Female Undisclosed Divorced 3-5 7 
Pt. 11 44 Female Part-time Single 1-3  5 
Pt. 12 39 Female Full-time Married > 1  8 
Pt. 13 54 Male Unemployed Widowed 5-10  10 
Pt. 14 64 Female Retired Married > 10 5 
Pt. 15 55 Male Full time Married 3-5 9 
Pt. 16 54 Female Part time Married  1-3 6 
Pt. 17 48 Female Unemployed Married >10  4 
Pt. 18 27 Female Unemployed Married 1-3 5 
Pt. 19 47 Male Full time Single >10 7 
 
 
